8 min read
Monthly FDA Guidance and Regulatory News Review - July 2026
This July 2026 regulatory update focuses on the FDA finalizing six guidances that addresses antiviral next-generation...
We understand how high the stakes are with gene therapy programs, and that nothing is standard about the study design, study conduct or regulatory process. Join us a the Cell & Gene Meeting On the Mesa to explore the technical and clinical achievements over the past 12 months in the areas of cell therapy, gene therapy, gene editing, tissue engineering and broader regenerative medicine technologies.
We understand that every cell and gene therapy is unique, involving a complicated regulatory approval process full of unknowns.
Veristat has assembled an extraordinary global team of experts in this field to help your study avoid errors in design, data collection, or analysis. We’re here to help you get your compound to market faster and positively impact patients’ lives.
Whether you are looking for a partner throughout the entire clinical development process or need additional functional support, Veristat scientific-minded experts can help you achieve success with the following:
Request a meeting with Denis Wilson or Jim Barrio on the event's Partnering One System. Log in here: https://informaconnect.com/cell-gene-meeting-on-the-mesa/login/
Visit the conference website to register or learn more:
https://www.meetingonthemesa.com/
8 min read
Aug 14, 2026 Veristat Blog
This July 2026 regulatory update focuses on the FDA finalizing six guidances that addresses antiviral next-generation...
1 min read
Aug 12, 2026 Veristat Blog
China is rapidly becoming one of the most influential forces in global drug development—but bringing innovative...